Immunolocalization of MUC1 in chronic plaque psoriasis

References

• Mansouri, Y.; Goldenberg, G. Biologic Safety in Psoriasis: Review of Long-term Safety Data. J. Clin. Aesthet. Dermatol. 2015, 8, 30–42.
   PubMedGoogle Scholar
• El‐Khateeb, E. A.;. The Spectrum of Paediatric Dermatoses in a University Hospital in Cairo. J. Eur. Acad. Dermatol. Venereol. 2011, 25, 666–672. DOI: 10.1111/j.1468-3083.2010.03846.x.
   PubMed Web of Science ®Google Scholar
• Ouédraogo, D. D.; Meyer, O. Psoriatic Arthritis in sub-Saharan Africa. Joint Bone Spine. 2012, 79, 17–19. DOI: 10.1016/j.jbspin.2011.06.007.
   PubMed Web of Science ®Google Scholar
• MA, L.; Suarez-Farinas, M.; Krueger, J. G. Immunology of Psoriasis. Annu. Rev. Immunol. 2014, 32, 227–255. DOI: 10.1146/annurev-immunol-032713-120225.
   PubMed Web of Science ®Google Scholar
• DW, K.;. MUC1-C Oncoprotein as a Target in Breast Cancer: Activation of Signaling Pathways and Therapeutic Approaches. Oncogene. 2013, 32, 1073–1081. DOI: 10.1038/onc.2012.158.
   PubMed Web of Science ®Google Scholar
• Cascio, S.; Faylo, J. L.; Sciurba, J. C.; Xue, J.; Ranganathan, S.; Lohmueller, J. J.; Beatty, P. L.; Finn, O. J. Abnormally Glycosylated MUC1 Establishes a Positive Feedback Circuit of Inflammatory Cytokines, Mediated by NF-κB Abnormally Glycosylated MUC1 Establishes a Positive Feedback Circuit of Inflammatory Cytokines, Mediated by NF-κB P65 and EzH2, in Colitis-associated Cancer. Oncotarget. 2017, 8, 105284–105298. DOI: 10.18632/oncotarget.22168.
   PubMedGoogle Scholar
• Liu, X.; Yi, C.; Wen, Y.; Radhakrishnan, P.; Tremayne, J. R.; Dao, T.; Johnson, K. R.; Hollingsworth, M. A. Interactions between MUC1 and P120 Catenin Regulate Dynamic Features of Cell Adhesion, Motility, and Metastasis. Cancer Res. 2014, 74, 1609–1620. DOI: 10.1158/0008-5472.CAN-13-2444.
   PubMed Web of Science ®Google Scholar
• Hollingsworth, M. A.; Swanson, B. J. Mucins in Cancer: Protection and Control of the Cell Surface. Nat. Rev. Cancer. 2004, 4, 45–60. DOI: 10.1038/nrc1251.
   PubMed Web of Science ®Google Scholar
• Zhao, Q.; Piyush, T.; Chen, C.; Hollingsworth, M. A.; Hilkens, J.; Rhodes, J. M.; Yu, L.-G. MUC1 Extracellular Domain Confers Resistance of Epithelial Cancer Cells to Anoikis. Cell Death Dis. 2014, 5, e1438. DOI: 10.1038/cddis.2014.421.
   PubMed Web of Science ®Google Scholar
• Kumar, P.; Ji, J.; Thirkill, T. L.; Douglas, G. C. MUC1 Is Expressed by Human Skin Fibroblasts and Plays a Role in Cell Adhesion and Migration. Biores. Open Access. 2014, 3, 45–52. DOI: 10.1089/biores.2013.0045.
   PubMedGoogle Scholar
• Louden, B. A.; Pearce, D. J.; Lang, W.; Feldman, S. R. A Simplified Psoriasis Area Severity Index (SPASI) for Rating Psoriasis Severity in Clinic Patients. Dermatol. Online J. 2004, 10, 7.
   PubMedGoogle Scholar
• Arciniegas, E.; Carrillo, L.M.; Páez, E. Presence of MUC1 in the Epidermal Thickening of Psoriatic Plaques. Histol. Histopathol. 2015, 30, 453–463. DOI: 10.14670/HH-30.453.
   PubMed Web of Science ®Google Scholar
• Sloane, J. P.; Ormerod, M. G. Distribution of Epithelial Membrane Antigen in Normal and Neoplastic Tissues and Its Value in Diagnostic Tumor Pathology. Cancer. 1981, 47, 1786–1795. DOI: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8.
   PubMed Web of Science ®Google Scholar
• Porowska, H.; Paszkiewicz-Gadek, A.; Wosek, J.; Wnuczko, K.; Rusak, M.; Szczepański, M. Expression of MUC1 Mucin in Human Umbilical Vein Endothelial Cells (HUVEC). Folia Histochem. Cytobiol. 2010, 48, 417–424. DOI: 10.2478/v10042-010-0027-x.
   PubMed Web of Science ®Google Scholar
• Cooper, H. L.; Cook, I. S.; Theaker, J. M. Expression and Glycosylation of MUC1 in Epidermolysis Bullosa‐associated and Sporadic Cutaneous Squamous Cell Carcinomas. Br. J. Dermatol. 2004, 151, 540–545. DOI: 10.1111/j.1365-2133.2004.06075.x.
   PubMed Web of Science ®Google Scholar
• Chakraborty, S.; Bonthu, N.; Swanson, B. J.; Batra, S. K. Role of Mucins in the Skin during Benign and Malignant Conditions. Cancer Lett. 2011, 301, 127–141. DOI: 10.1016/j.canlet.2010.11.004.
   PubMed Web of Science ®Google Scholar
• Walsh, M. D.; Luckie, S. M.; Cummings, M. C.; Antalis, T. M.; McGuckin, M. A. Heterogeneity of MUC1 Expression by Human Breast Carcinoma Cell Lines in Vivo and in Vitro. Breast Cancer Res. Treat. 1999, 58, 255–266.
   PubMed Web of Science ®Google Scholar
• Vasir, B.; Avigan, D.; Wu, Z.; Crawford, K.; Turnquist, S.; Ren, J.; Kufe, D. Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-dependent Mechanism. J. Immunol. 2005, 174, 2376–2386. DOI: 10.4049/jimmunol.174.4.2376.
   PubMed Web of Science ®Google Scholar
• Arciniegas, E.; Carrillo, L. M.; Rojas, H. Mucin1 Expression in Focal Epidermal Dysplasia of Actinic Keratosis. Ann. Transl. Med. 2015, 3, 245.
   PubMed Web of Science ®Google Scholar
• Ryan, C.; Korman, N. J.; Gelfand, J. M.; Lim, H. W.; Elmets, C. A.; Feldman, S. R.; Gottlieb, A. B.; Koo, J. Y. M.; Lebwohl, M.; Leonardi, C. L.; et al. Research Gaps in Psoriasis: Opportunities for Future Studies. J. Am. Acad. Dermatol. 2014, 70, 146–167. DOI: 10.1016/j.jaad.2013.08.042.
   PubMed Web of Science ®Google Scholar
• Phan, C.; Sigal, M. L.; Estève, E.; Reguiai, Z.; Barthélémy, H.; Beneton, N.; Maccari, F.; Lahfa, M.; Thomas-Beaulieu, D.; Le Guyadec, T.; et al. Psoriasis in the Elderly: Epidemiological and Clinical Aspects, and Evaluation of Patients with Very Late Onset Psoriasis. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 78–82. DOI: 10.1111/jdv.12850.
   PubMed Web of Science ®Google Scholar
• Bazan-Arruda, A. C.; Siqueira, D. M.; Mercadante, L. M. The Role of Angiogenesis in the Development of Psoriasis. In Angiogenesis-Based Dermatology; Arbiser, J. L., Ed.; Springer: London, 2017; pp 41–66.
   Google Scholar
• Výbohová, D.; Adamicová, K.; Mellová, Y.; Hešková, G. Microvascular Changes in Relation to Inflammation and Epidermal Hyperplasia in Chronic Cutaneous Lesions of Psoriasis Vulgaris. Histol. Histopathol. 2017, 32, 461–470. DOI: 10.14670/HH-11-811.
   PubMed Web of Science ®Google Scholar
• Jain, S.; Stroopinsky, D.; Yin, L.; Rosenblatt, J.; Alam, M.; Bhargava, P.; Clark, R. A.; Kupper, T. S.; Palmer, K.; Coll, M. D.; et al. Mucin 1 Is a Potential Therapeutic Target in Cutaneous T-cell Lymphoma. Blood. 2015, 126, 354–362. DOI: 10.1182/blood-2015-02-628149.
   PubMed Web of Science ®Google Scholar
• Wu, G.; Kim, D.; JN, K.; Park, S.; Maharjan, S.; Koh, H.; Moon, K.; Lee, Y.; Kwon, H.-J. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer. Theranostics. 2018, 8, 78–91. DOI: 10.7150/thno.21278.
   PubMed Web of Science ®Google Scholar
• Wu, G.; Maharjan, S.; Kim, D. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model. Int. J. Mol. Sci. 2018, 19(7). DOI:10.3390/ijms19072004.
   Web of Science ®Google Scholar
• Wang, X.; Lan, H.; Li, J.; Su, Y.; Xu, L. Muc1 Promotes Migration and Lung Metastasis of Melanoma Cells. Am. J. Cancer Res. 2015, 5, 2590–2604.
   PubMed Web of Science ®Google Scholar
• Xin, Z.; Xin, G.; Shi, M.; Song, L.; Wang, Q.; Jiang, B.; Liu, X. Inhibition of MUc1-c Entering Nuclear Suppresses MYc Expression and Attenuates Malignant Growth in Esophageal Squamous Cell Carcinoma. Onco. Targets Ther. 2018, 11, 4125–4136. DOI: 10.2147/OTT.S168813.
   PubMed Web of Science ®Google Scholar